CorestemChemon
Company Details
Status: Private
Employees: 11-50
Location:
Seongnam-si, Gyeonggi-do
Type:
sample
Technology:
sample
sample
sample
sample
About: CorestemChemon is a global biotechnology corporation centered on stem cell-based new drug development and non-clinical research divisions.
Motivated by the urgent need for medication for patients, the bio-pharmaceuticals division remains dedicated to research and development.
In 2014, the unit successfully commercialized Neuronata-R inj, a stem cell therapy for the rare disease Amyotrophic Lateral Sclerosis (ALS), making it the fifth stem cell therapy approved for use globally.
Alongside ALS treatment, the division has pipelines for various diseases such as lupus, Neuromyelitis Optica (NMO), and multiple system atrophy (MSA). Leveraging the success of the ALS stem cell therapy, the unit plans to concentrate on developing treatments for rare and incurable neurological and autoimmune diseases to dominate new market.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
CorestemChemon | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.